![](../../files/images/goods/2351882-11-4.png)
Spastazoline
CAS No. 2351882-11-4
Spastazoline ( —— )
产品货号. M21959 CAS No. 2351882-11-4
Spastazoline 是 spastin(Human spastin,IC50 为 99 nM)的有效选择性抑制剂。
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥915 | 有现货 |
![]() ![]() |
10MG | ¥1531 | 有现货 |
![]() ![]() |
25MG | ¥3062 | 有现货 |
![]() ![]() |
50MG | ¥4601 | 有现货 |
![]() ![]() |
100MG | ¥6602 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Spastazoline
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Spastazoline 是 spastin(Human spastin,IC50 为 99 nM)的有效选择性抑制剂。
-
产品描述Spastazoline is a potent and selective inhibitor of spastin(Human spastin with IC50 of 99 nM).?
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体spastin
-
研究领域——
-
适应症——
化学信息
-
CAS Number2351882-11-4
-
分子量382.51
-
分子式C20H30N8
-
纯度>98% (HPLC)
-
溶解度DMSO:95 mg/ml(248.36 mM; Need ultrasonic)
-
SMILESCC(C)[C@@H]1CN(CCN1)c1nc(Nc2cc([nH]n2)C(C)(C)C)c2cc[nH]c2n1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Cupido T, et al. Designing a chemical inhibitor for the AAA protein spastin using active site mutations. Nat Chem Biol. 2019 Feb 18.2. Pisa R , Cupido T , Steinman J B , et al. Analyzing Resistance to Design Selective Chemical Inhibitors for AAA Proteins[J]. Cell Chemical Biology, 2019, 26(9).
产品手册
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/gift.jpg)
![](/themes/theme/en/images/ct2.png)
关联产品
-
Cucurbitacin IIb
葫芦素IIb是Hemsleyadine片剂的主要活性化合物之一,临床用于治疗细菌性痢疾、肠炎和急性扁桃体炎。
-
Gelsevirine
Gelsevirine 是钩吻花中的主要生物碱,具有有效的抗焦虑作用。 Gelsevirine 的抗焦虑机制可能与大脑中甘氨酸受体的激动作用有关。
-
Osteogenic Growth Pe...
Osteogenic Growth Peptide, OGP is a short, naturally occurring 14-mer growth factor peptide found in serum at μM concentrations. Osteogenic growth peptide OGP is a key factor in the mechanism of the systemic osteogenic response to local bone marrow injury.